Hypothesis

If aging is an evolutionarily conserved population‑level program, then interventions that merely reduce molecular damage will trigger compensatory activation of the program, limiting their efficacy. True longevity gains require modulating the program’s set‑point rather than overriding it. This perspective shifts the focus from damage attenuation to program modulation.

Mechanistic Basis

Recent causal‑inference work links gut microbiota to frailty and facial aging through biomarkers such as telomere length [1][2]. This suggests microbes influence a regulated signaling hub. We propose that this hub is the VEGFR1‑YAP1 mechanical feedback loop, which senses extracellular matrix stiffness and transduces shear stress into a transcriptional senescence response [3]. In young endothelium, laminar flow keeps YAP1 cytoplasmic, suppressing senescence‑associated secretory phenotype (SASP). With age, altered flow and matrix stiffness shift YAP1 nuclear, activating a conserved program that limits resource use by older individuals. Genetic variants affecting gut‑derived metabolites (e.g., short‑chain fatty acids) act as instrumental variables that modulate integrin signaling, thereby influencing VEGFR1 activity and YAP1 localization [4].

Testable Predictions

1. Mendelian randomization using SNPs associated with butyrate‑producing microbes will show a causal effect on nuclear YAP1 levels in circulating endothelial progenitors, mediated by telomere length and frailty index [5].
2. Target‑trial emulation of senolytics versus VEGFR1‑YAP1 pathway inhibitors will reveal that only the latter produce a coordinated downregulation of SASP factors without triggering a compensatory increase in p16^INK4a expression [6].
3. In aged mice, transplanting a youthful microbiota will reduce nuclear YAP1 in aortic endothelium only when accompanied by exogenous nitrate supplementation that restores shear stress signaling; microbiota change alone will not alter YAP1 localization [7].

Falsification Criteria

If MR analyses find no association between microbiota‑related SNPs and YAP1 nuclear localization, or if pathway inhibition fails to lower SASP while increasing other senescence markers, the hypothesis that aging is a regulated program tunable via this mechanosensory loop is refuted. Conversely, confirmation would support the view that longevity medicine must negotiate with an evolutionarily preserved program rather than simply repair damage.